Global Immunological Agents Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Immunological Agents market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Immunological Agents market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Immunological Agents market size and forecasts, in consumption value ($ Million), 2018-2029
Global Immunological Agents market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Immunological Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Immunological Agents market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immunological Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immunological Agents market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Organon, Pfizer, Sandoz and Amneal Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Immunological Agents market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Immunological Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immunological Agents, with revenue, gross margin and global market share of Immunological Agents from 2018 to 2023.
Chapter 3, the Immunological Agents competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Immunological Agents market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Immunological Agents.
Chapter 13, to describe Immunological Agents research findings and conclusion.
This report is a detailed and comprehensive analysis for global Immunological Agents market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Immunological Agents market size and forecasts, in consumption value ($ Million), 2018-2029
Global Immunological Agents market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Immunological Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Immunological Agents market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immunological Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immunological Agents market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Organon, Pfizer, Sandoz and Amneal Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Immunological Agents market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Antirheumatic Drugs (DMARDs)
- Immune Globulins
- Immunomodulatory Agents
- Immunosuppressive Agents
- Monoclonal Antibodies
- Other
- Hospital
- Clinics
- Others
- Abbott
- Organon
- Pfizer
- Sandoz
- Amneal Pharmaceuticals
- Apotex
- Teva Pharmaceuticals
- Biocon
- Bristol Myers Squibb
- Merck
- CSL Behring
- Sanofi
- Leading Pharma
- Accord Healthcare Inc
- Amgen
- Nabi Biopharmaceuticals
- Ascend Laboratories
- Camber Pharmaceuticals Inc
- Grifols USA
- JOM Pharmaceuticals
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Immunological Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immunological Agents, with revenue, gross margin and global market share of Immunological Agents from 2018 to 2023.
Chapter 3, the Immunological Agents competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Immunological Agents market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Immunological Agents.
Chapter 13, to describe Immunological Agents research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Immunological Agents
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Immunological Agents by Type
1.3.1 Overview: Global Immunological Agents Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Immunological Agents Consumption Value Market Share by Type in 2022
1.3.3 Antirheumatic Drugs (DMARDs)
1.3.4 Immune Globulins
1.3.5 Immunomodulatory Agents
1.3.6 Immunosuppressive Agents
1.3.7 Monoclonal Antibodies
1.3.8 Other
1.4 Global Immunological Agents Market by Application
1.4.1 Overview: Global Immunological Agents Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinics
1.4.4 Others
1.5 Global Immunological Agents Market Size & Forecast
1.6 Global Immunological Agents Market Size and Forecast by Region
1.6.1 Global Immunological Agents Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Immunological Agents Market Size by Region, (2018-2029)
1.6.3 North America Immunological Agents Market Size and Prospect (2018-2029)
1.6.4 Europe Immunological Agents Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Immunological Agents Market Size and Prospect (2018-2029)
1.6.6 South America Immunological Agents Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Immunological Agents Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Immunological Agents Product and Solutions
2.1.4 Abbott Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Organon
2.2.1 Organon Details
2.2.2 Organon Major Business
2.2.3 Organon Immunological Agents Product and Solutions
2.2.4 Organon Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Organon Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Immunological Agents Product and Solutions
2.3.4 Pfizer Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Sandoz
2.4.1 Sandoz Details
2.4.2 Sandoz Major Business
2.4.3 Sandoz Immunological Agents Product and Solutions
2.4.4 Sandoz Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sandoz Recent Developments and Future Plans
2.5 Amneal Pharmaceuticals
2.5.1 Amneal Pharmaceuticals Details
2.5.2 Amneal Pharmaceuticals Major Business
2.5.3 Amneal Pharmaceuticals Immunological Agents Product and Solutions
2.5.4 Amneal Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Amneal Pharmaceuticals Recent Developments and Future Plans
2.6 Apotex
2.6.1 Apotex Details
2.6.2 Apotex Major Business
2.6.3 Apotex Immunological Agents Product and Solutions
2.6.4 Apotex Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Apotex Recent Developments and Future Plans
2.7 Teva Pharmaceuticals
2.7.1 Teva Pharmaceuticals Details
2.7.2 Teva Pharmaceuticals Major Business
2.7.3 Teva Pharmaceuticals Immunological Agents Product and Solutions
2.7.4 Teva Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Teva Pharmaceuticals Recent Developments and Future Plans
2.8 Biocon
2.8.1 Biocon Details
2.8.2 Biocon Major Business
2.8.3 Biocon Immunological Agents Product and Solutions
2.8.4 Biocon Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Biocon Recent Developments and Future Plans
2.9 Bristol Myers Squibb
2.9.1 Bristol Myers Squibb Details
2.9.2 Bristol Myers Squibb Major Business
2.9.3 Bristol Myers Squibb Immunological Agents Product and Solutions
2.9.4 Bristol Myers Squibb Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bristol Myers Squibb Recent Developments and Future Plans
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business
2.10.3 Merck Immunological Agents Product and Solutions
2.10.4 Merck Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merck Recent Developments and Future Plans
2.11 CSL Behring
2.11.1 CSL Behring Details
2.11.2 CSL Behring Major Business
2.11.3 CSL Behring Immunological Agents Product and Solutions
2.11.4 CSL Behring Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CSL Behring Recent Developments and Future Plans
2.12 Sanofi
2.12.1 Sanofi Details
2.12.2 Sanofi Major Business
2.12.3 Sanofi Immunological Agents Product and Solutions
2.12.4 Sanofi Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sanofi Recent Developments and Future Plans
2.13 Leading Pharma
2.13.1 Leading Pharma Details
2.13.2 Leading Pharma Major Business
2.13.3 Leading Pharma Immunological Agents Product and Solutions
2.13.4 Leading Pharma Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Leading Pharma Recent Developments and Future Plans
2.14 Accord Healthcare Inc
2.14.1 Accord Healthcare Inc Details
2.14.2 Accord Healthcare Inc Major Business
2.14.3 Accord Healthcare Inc Immunological Agents Product and Solutions
2.14.4 Accord Healthcare Inc Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Accord Healthcare Inc Recent Developments and Future Plans
2.15 Amgen
2.15.1 Amgen Details
2.15.2 Amgen Major Business
2.15.3 Amgen Immunological Agents Product and Solutions
2.15.4 Amgen Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Amgen Recent Developments and Future Plans
2.16 Nabi Biopharmaceuticals
2.16.1 Nabi Biopharmaceuticals Details
2.16.2 Nabi Biopharmaceuticals Major Business
2.16.3 Nabi Biopharmaceuticals Immunological Agents Product and Solutions
2.16.4 Nabi Biopharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Nabi Biopharmaceuticals Recent Developments and Future Plans
2.17 Ascend Laboratories
2.17.1 Ascend Laboratories Details
2.17.2 Ascend Laboratories Major Business
2.17.3 Ascend Laboratories Immunological Agents Product and Solutions
2.17.4 Ascend Laboratories Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Ascend Laboratories Recent Developments and Future Plans
2.18 Camber Pharmaceuticals Inc
2.18.1 Camber Pharmaceuticals Inc Details
2.18.2 Camber Pharmaceuticals Inc Major Business
2.18.3 Camber Pharmaceuticals Inc Immunological Agents Product and Solutions
2.18.4 Camber Pharmaceuticals Inc Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Camber Pharmaceuticals Inc Recent Developments and Future Plans
2.19 Grifols USA
2.19.1 Grifols USA Details
2.19.2 Grifols USA Major Business
2.19.3 Grifols USA Immunological Agents Product and Solutions
2.19.4 Grifols USA Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Grifols USA Recent Developments and Future Plans
2.20 JOM Pharmaceuticals
2.20.1 JOM Pharmaceuticals Details
2.20.2 JOM Pharmaceuticals Major Business
2.20.3 JOM Pharmaceuticals Immunological Agents Product and Solutions
2.20.4 JOM Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 JOM Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Immunological Agents Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Immunological Agents by Company Revenue
3.2.2 Top 3 Immunological Agents Players Market Share in 2022
3.2.3 Top 6 Immunological Agents Players Market Share in 2022
3.3 Immunological Agents Market: Overall Company Footprint Analysis
3.3.1 Immunological Agents Market: Region Footprint
3.3.2 Immunological Agents Market: Company Product Type Footprint
3.3.3 Immunological Agents Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Immunological Agents Consumption Value and Market Share by Type (2018-2023)
4.2 Global Immunological Agents Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Immunological Agents Consumption Value Market Share by Application (2018-2023)
5.2 Global Immunological Agents Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Immunological Agents Consumption Value by Type (2018-2029)
6.2 North America Immunological Agents Consumption Value by Application (2018-2029)
6.3 North America Immunological Agents Market Size by Country
6.3.1 North America Immunological Agents Consumption Value by Country (2018-2029)
6.3.2 United States Immunological Agents Market Size and Forecast (2018-2029)
6.3.3 Canada Immunological Agents Market Size and Forecast (2018-2029)
6.3.4 Mexico Immunological Agents Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Immunological Agents Consumption Value by Type (2018-2029)
7.2 Europe Immunological Agents Consumption Value by Application (2018-2029)
7.3 Europe Immunological Agents Market Size by Country
7.3.1 Europe Immunological Agents Consumption Value by Country (2018-2029)
7.3.2 Germany Immunological Agents Market Size and Forecast (2018-2029)
7.3.3 France Immunological Agents Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Immunological Agents Market Size and Forecast (2018-2029)
7.3.5 Russia Immunological Agents Market Size and Forecast (2018-2029)
7.3.6 Italy Immunological Agents Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Immunological Agents Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Immunological Agents Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Immunological Agents Market Size by Region
8.3.1 Asia-Pacific Immunological Agents Consumption Value by Region (2018-2029)
8.3.2 China Immunological Agents Market Size and Forecast (2018-2029)
8.3.3 Japan Immunological Agents Market Size and Forecast (2018-2029)
8.3.4 South Korea Immunological Agents Market Size and Forecast (2018-2029)
8.3.5 India Immunological Agents Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Immunological Agents Market Size and Forecast (2018-2029)
8.3.7 Australia Immunological Agents Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Immunological Agents Consumption Value by Type (2018-2029)
9.2 South America Immunological Agents Consumption Value by Application (2018-2029)
9.3 South America Immunological Agents Market Size by Country
9.3.1 South America Immunological Agents Consumption Value by Country (2018-2029)
9.3.2 Brazil Immunological Agents Market Size and Forecast (2018-2029)
9.3.3 Argentina Immunological Agents Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Immunological Agents Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Immunological Agents Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Immunological Agents Market Size by Country
10.3.1 Middle East & Africa Immunological Agents Consumption Value by Country (2018-2029)
10.3.2 Turkey Immunological Agents Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Immunological Agents Market Size and Forecast (2018-2029)
10.3.4 UAE Immunological Agents Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Immunological Agents Market Drivers
11.2 Immunological Agents Market Restraints
11.3 Immunological Agents Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Immunological Agents Industry Chain
12.2 Immunological Agents Upstream Analysis
12.3 Immunological Agents Midstream Analysis
12.4 Immunological Agents Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Immunological Agents
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Immunological Agents by Type
1.3.1 Overview: Global Immunological Agents Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Immunological Agents Consumption Value Market Share by Type in 2022
1.3.3 Antirheumatic Drugs (DMARDs)
1.3.4 Immune Globulins
1.3.5 Immunomodulatory Agents
1.3.6 Immunosuppressive Agents
1.3.7 Monoclonal Antibodies
1.3.8 Other
1.4 Global Immunological Agents Market by Application
1.4.1 Overview: Global Immunological Agents Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinics
1.4.4 Others
1.5 Global Immunological Agents Market Size & Forecast
1.6 Global Immunological Agents Market Size and Forecast by Region
1.6.1 Global Immunological Agents Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Immunological Agents Market Size by Region, (2018-2029)
1.6.3 North America Immunological Agents Market Size and Prospect (2018-2029)
1.6.4 Europe Immunological Agents Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Immunological Agents Market Size and Prospect (2018-2029)
1.6.6 South America Immunological Agents Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Immunological Agents Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Immunological Agents Product and Solutions
2.1.4 Abbott Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Organon
2.2.1 Organon Details
2.2.2 Organon Major Business
2.2.3 Organon Immunological Agents Product and Solutions
2.2.4 Organon Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Organon Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Immunological Agents Product and Solutions
2.3.4 Pfizer Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Sandoz
2.4.1 Sandoz Details
2.4.2 Sandoz Major Business
2.4.3 Sandoz Immunological Agents Product and Solutions
2.4.4 Sandoz Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sandoz Recent Developments and Future Plans
2.5 Amneal Pharmaceuticals
2.5.1 Amneal Pharmaceuticals Details
2.5.2 Amneal Pharmaceuticals Major Business
2.5.3 Amneal Pharmaceuticals Immunological Agents Product and Solutions
2.5.4 Amneal Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Amneal Pharmaceuticals Recent Developments and Future Plans
2.6 Apotex
2.6.1 Apotex Details
2.6.2 Apotex Major Business
2.6.3 Apotex Immunological Agents Product and Solutions
2.6.4 Apotex Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Apotex Recent Developments and Future Plans
2.7 Teva Pharmaceuticals
2.7.1 Teva Pharmaceuticals Details
2.7.2 Teva Pharmaceuticals Major Business
2.7.3 Teva Pharmaceuticals Immunological Agents Product and Solutions
2.7.4 Teva Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Teva Pharmaceuticals Recent Developments and Future Plans
2.8 Biocon
2.8.1 Biocon Details
2.8.2 Biocon Major Business
2.8.3 Biocon Immunological Agents Product and Solutions
2.8.4 Biocon Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Biocon Recent Developments and Future Plans
2.9 Bristol Myers Squibb
2.9.1 Bristol Myers Squibb Details
2.9.2 Bristol Myers Squibb Major Business
2.9.3 Bristol Myers Squibb Immunological Agents Product and Solutions
2.9.4 Bristol Myers Squibb Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bristol Myers Squibb Recent Developments and Future Plans
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business
2.10.3 Merck Immunological Agents Product and Solutions
2.10.4 Merck Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merck Recent Developments and Future Plans
2.11 CSL Behring
2.11.1 CSL Behring Details
2.11.2 CSL Behring Major Business
2.11.3 CSL Behring Immunological Agents Product and Solutions
2.11.4 CSL Behring Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CSL Behring Recent Developments and Future Plans
2.12 Sanofi
2.12.1 Sanofi Details
2.12.2 Sanofi Major Business
2.12.3 Sanofi Immunological Agents Product and Solutions
2.12.4 Sanofi Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sanofi Recent Developments and Future Plans
2.13 Leading Pharma
2.13.1 Leading Pharma Details
2.13.2 Leading Pharma Major Business
2.13.3 Leading Pharma Immunological Agents Product and Solutions
2.13.4 Leading Pharma Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Leading Pharma Recent Developments and Future Plans
2.14 Accord Healthcare Inc
2.14.1 Accord Healthcare Inc Details
2.14.2 Accord Healthcare Inc Major Business
2.14.3 Accord Healthcare Inc Immunological Agents Product and Solutions
2.14.4 Accord Healthcare Inc Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Accord Healthcare Inc Recent Developments and Future Plans
2.15 Amgen
2.15.1 Amgen Details
2.15.2 Amgen Major Business
2.15.3 Amgen Immunological Agents Product and Solutions
2.15.4 Amgen Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Amgen Recent Developments and Future Plans
2.16 Nabi Biopharmaceuticals
2.16.1 Nabi Biopharmaceuticals Details
2.16.2 Nabi Biopharmaceuticals Major Business
2.16.3 Nabi Biopharmaceuticals Immunological Agents Product and Solutions
2.16.4 Nabi Biopharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Nabi Biopharmaceuticals Recent Developments and Future Plans
2.17 Ascend Laboratories
2.17.1 Ascend Laboratories Details
2.17.2 Ascend Laboratories Major Business
2.17.3 Ascend Laboratories Immunological Agents Product and Solutions
2.17.4 Ascend Laboratories Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Ascend Laboratories Recent Developments and Future Plans
2.18 Camber Pharmaceuticals Inc
2.18.1 Camber Pharmaceuticals Inc Details
2.18.2 Camber Pharmaceuticals Inc Major Business
2.18.3 Camber Pharmaceuticals Inc Immunological Agents Product and Solutions
2.18.4 Camber Pharmaceuticals Inc Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Camber Pharmaceuticals Inc Recent Developments and Future Plans
2.19 Grifols USA
2.19.1 Grifols USA Details
2.19.2 Grifols USA Major Business
2.19.3 Grifols USA Immunological Agents Product and Solutions
2.19.4 Grifols USA Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Grifols USA Recent Developments and Future Plans
2.20 JOM Pharmaceuticals
2.20.1 JOM Pharmaceuticals Details
2.20.2 JOM Pharmaceuticals Major Business
2.20.3 JOM Pharmaceuticals Immunological Agents Product and Solutions
2.20.4 JOM Pharmaceuticals Immunological Agents Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 JOM Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Immunological Agents Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Immunological Agents by Company Revenue
3.2.2 Top 3 Immunological Agents Players Market Share in 2022
3.2.3 Top 6 Immunological Agents Players Market Share in 2022
3.3 Immunological Agents Market: Overall Company Footprint Analysis
3.3.1 Immunological Agents Market: Region Footprint
3.3.2 Immunological Agents Market: Company Product Type Footprint
3.3.3 Immunological Agents Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Immunological Agents Consumption Value and Market Share by Type (2018-2023)
4.2 Global Immunological Agents Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Immunological Agents Consumption Value Market Share by Application (2018-2023)
5.2 Global Immunological Agents Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Immunological Agents Consumption Value by Type (2018-2029)
6.2 North America Immunological Agents Consumption Value by Application (2018-2029)
6.3 North America Immunological Agents Market Size by Country
6.3.1 North America Immunological Agents Consumption Value by Country (2018-2029)
6.3.2 United States Immunological Agents Market Size and Forecast (2018-2029)
6.3.3 Canada Immunological Agents Market Size and Forecast (2018-2029)
6.3.4 Mexico Immunological Agents Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Immunological Agents Consumption Value by Type (2018-2029)
7.2 Europe Immunological Agents Consumption Value by Application (2018-2029)
7.3 Europe Immunological Agents Market Size by Country
7.3.1 Europe Immunological Agents Consumption Value by Country (2018-2029)
7.3.2 Germany Immunological Agents Market Size and Forecast (2018-2029)
7.3.3 France Immunological Agents Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Immunological Agents Market Size and Forecast (2018-2029)
7.3.5 Russia Immunological Agents Market Size and Forecast (2018-2029)
7.3.6 Italy Immunological Agents Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Immunological Agents Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Immunological Agents Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Immunological Agents Market Size by Region
8.3.1 Asia-Pacific Immunological Agents Consumption Value by Region (2018-2029)
8.3.2 China Immunological Agents Market Size and Forecast (2018-2029)
8.3.3 Japan Immunological Agents Market Size and Forecast (2018-2029)
8.3.4 South Korea Immunological Agents Market Size and Forecast (2018-2029)
8.3.5 India Immunological Agents Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Immunological Agents Market Size and Forecast (2018-2029)
8.3.7 Australia Immunological Agents Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Immunological Agents Consumption Value by Type (2018-2029)
9.2 South America Immunological Agents Consumption Value by Application (2018-2029)
9.3 South America Immunological Agents Market Size by Country
9.3.1 South America Immunological Agents Consumption Value by Country (2018-2029)
9.3.2 Brazil Immunological Agents Market Size and Forecast (2018-2029)
9.3.3 Argentina Immunological Agents Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Immunological Agents Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Immunological Agents Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Immunological Agents Market Size by Country
10.3.1 Middle East & Africa Immunological Agents Consumption Value by Country (2018-2029)
10.3.2 Turkey Immunological Agents Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Immunological Agents Market Size and Forecast (2018-2029)
10.3.4 UAE Immunological Agents Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Immunological Agents Market Drivers
11.2 Immunological Agents Market Restraints
11.3 Immunological Agents Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Immunological Agents Industry Chain
12.2 Immunological Agents Upstream Analysis
12.3 Immunological Agents Midstream Analysis
12.4 Immunological Agents Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Immunological Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Immunological Agents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Immunological Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Immunological Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Abbott Company Information, Head Office, and Major Competitors
Table 6. Abbott Major Business
Table 7. Abbott Immunological Agents Product and Solutions
Table 8. Abbott Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Abbott Recent Developments and Future Plans
Table 10. Organon Company Information, Head Office, and Major Competitors
Table 11. Organon Major Business
Table 12. Organon Immunological Agents Product and Solutions
Table 13. Organon Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Organon Recent Developments and Future Plans
Table 15. Pfizer Company Information, Head Office, and Major Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Immunological Agents Product and Solutions
Table 18. Pfizer Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Pfizer Recent Developments and Future Plans
Table 20. Sandoz Company Information, Head Office, and Major Competitors
Table 21. Sandoz Major Business
Table 22. Sandoz Immunological Agents Product and Solutions
Table 23. Sandoz Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Sandoz Recent Developments and Future Plans
Table 25. Amneal Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 26. Amneal Pharmaceuticals Major Business
Table 27. Amneal Pharmaceuticals Immunological Agents Product and Solutions
Table 28. Amneal Pharmaceuticals Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Amneal Pharmaceuticals Recent Developments and Future Plans
Table 30. Apotex Company Information, Head Office, and Major Competitors
Table 31. Apotex Major Business
Table 32. Apotex Immunological Agents Product and Solutions
Table 33. Apotex Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Apotex Recent Developments and Future Plans
Table 35. Teva Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 36. Teva Pharmaceuticals Major Business
Table 37. Teva Pharmaceuticals Immunological Agents Product and Solutions
Table 38. Teva Pharmaceuticals Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Teva Pharmaceuticals Recent Developments and Future Plans
Table 40. Biocon Company Information, Head Office, and Major Competitors
Table 41. Biocon Major Business
Table 42. Biocon Immunological Agents Product and Solutions
Table 43. Biocon Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Biocon Recent Developments and Future Plans
Table 45. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
Table 46. Bristol Myers Squibb Major Business
Table 47. Bristol Myers Squibb Immunological Agents Product and Solutions
Table 48. Bristol Myers Squibb Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Bristol Myers Squibb Recent Developments and Future Plans
Table 50. Merck Company Information, Head Office, and Major Competitors
Table 51. Merck Major Business
Table 52. Merck Immunological Agents Product and Solutions
Table 53. Merck Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Merck Recent Developments and Future Plans
Table 55. CSL Behring Company Information, Head Office, and Major Competitors
Table 56. CSL Behring Major Business
Table 57. CSL Behring Immunological Agents Product and Solutions
Table 58. CSL Behring Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. CSL Behring Recent Developments and Future Plans
Table 60. Sanofi Company Information, Head Office, and Major Competitors
Table 61. Sanofi Major Business
Table 62. Sanofi Immunological Agents Product and Solutions
Table 63. Sanofi Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Sanofi Recent Developments and Future Plans
Table 65. Leading Pharma Company Information, Head Office, and Major Competitors
Table 66. Leading Pharma Major Business
Table 67. Leading Pharma Immunological Agents Product and Solutions
Table 68. Leading Pharma Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Leading Pharma Recent Developments and Future Plans
Table 70. Accord Healthcare Inc Company Information, Head Office, and Major Competitors
Table 71. Accord Healthcare Inc Major Business
Table 72. Accord Healthcare Inc Immunological Agents Product and Solutions
Table 73. Accord Healthcare Inc Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Accord Healthcare Inc Recent Developments and Future Plans
Table 75. Amgen Company Information, Head Office, and Major Competitors
Table 76. Amgen Major Business
Table 77. Amgen Immunological Agents Product and Solutions
Table 78. Amgen Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Amgen Recent Developments and Future Plans
Table 80. Nabi Biopharmaceuticals Company Information, Head Office, and Major Competitors
Table 81. Nabi Biopharmaceuticals Major Business
Table 82. Nabi Biopharmaceuticals Immunological Agents Product and Solutions
Table 83. Nabi Biopharmaceuticals Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Nabi Biopharmaceuticals Recent Developments and Future Plans
Table 85. Ascend Laboratories Company Information, Head Office, and Major Competitors
Table 86. Ascend Laboratories Major Business
Table 87. Ascend Laboratories Immunological Agents Product and Solutions
Table 88. Ascend Laboratories Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Ascend Laboratories Recent Developments and Future Plans
Table 90. Camber Pharmaceuticals Inc Company Information, Head Office, and Major Competitors
Table 91. Camber Pharmaceuticals Inc Major Business
Table 92. Camber Pharmaceuticals Inc Immunological Agents Product and Solutions
Table 93. Camber Pharmaceuticals Inc Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Camber Pharmaceuticals Inc Recent Developments and Future Plans
Table 95. Grifols USA Company Information, Head Office, and Major Competitors
Table 96. Grifols USA Major Business
Table 97. Grifols USA Immunological Agents Product and Solutions
Table 98. Grifols USA Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Grifols USA Recent Developments and Future Plans
Table 100. JOM Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 101. JOM Pharmaceuticals Major Business
Table 102. JOM Pharmaceuticals Immunological Agents Product and Solutions
Table 103. JOM Pharmaceuticals Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. JOM Pharmaceuticals Recent Developments and Future Plans
Table 105. Global Immunological Agents Revenue (USD Million) by Players (2018-2023)
Table 106. Global Immunological Agents Revenue Share by Players (2018-2023)
Table 107. Breakdown of Immunological Agents by Company Type (Tier 1, Tier 2, and Tier 3)
Table 108. Market Position of Players in Immunological Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 109. Head Office of Key Immunological Agents Players
Table 110. Immunological Agents Market: Company Product Type Footprint
Table 111. Immunological Agents Market: Company Product Application Footprint
Table 112. Immunological Agents New Market Entrants and Barriers to Market Entry
Table 113. Immunological Agents Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Immunological Agents Consumption Value (USD Million) by Type (2018-2023)
Table 115. Global Immunological Agents Consumption Value Share by Type (2018-2023)
Table 116. Global Immunological Agents Consumption Value Forecast by Type (2024-2029)
Table 117. Global Immunological Agents Consumption Value by Application (2018-2023)
Table 118. Global Immunological Agents Consumption Value Forecast by Application (2024-2029)
Table 119. North America Immunological Agents Consumption Value by Type (2018-2023) & (USD Million)
Table 120. North America Immunological Agents Consumption Value by Type (2024-2029) & (USD Million)
Table 121. North America Immunological Agents Consumption Value by Application (2018-2023) & (USD Million)
Table 122. North America Immunological Agents Consumption Value by Application (2024-2029) & (USD Million)
Table 123. North America Immunological Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 124. North America Immunological Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 125. Europe Immunological Agents Consumption Value by Type (2018-2023) & (USD Million)
Table 126. Europe Immunological Agents Consumption Value by Type (2024-2029) & (USD Million)
Table 127. Europe Immunological Agents Consumption Value by Application (2018-2023) & (USD Million)
Table 128. Europe Immunological Agents Consumption Value by Application (2024-2029) & (USD Million)
Table 129. Europe Immunological Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Immunological Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Immunological Agents Consumption Value by Type (2018-2023) & (USD Million)
Table 132. Asia-Pacific Immunological Agents Consumption Value by Type (2024-2029) & (USD Million)
Table 133. Asia-Pacific Immunological Agents Consumption Value by Application (2018-2023) & (USD Million)
Table 134. Asia-Pacific Immunological Agents Consumption Value by Application (2024-2029) & (USD Million)
Table 135. Asia-Pacific Immunological Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 136. Asia-Pacific Immunological Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 137. South America Immunological Agents Consumption Value by Type (2018-2023) & (USD Million)
Table 138. South America Immunological Agents Consumption Value by Type (2024-2029) & (USD Million)
Table 139. South America Immunological Agents Consumption Value by Application (2018-2023) & (USD Million)
Table 140. South America Immunological Agents Consumption Value by Application (2024-2029) & (USD Million)
Table 141. South America Immunological Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 142. South America Immunological Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 143. Middle East & Africa Immunological Agents Consumption Value by Type (2018-2023) & (USD Million)
Table 144. Middle East & Africa Immunological Agents Consumption Value by Type (2024-2029) & (USD Million)
Table 145. Middle East & Africa Immunological Agents Consumption Value by Application (2018-2023) & (USD Million)
Table 146. Middle East & Africa Immunological Agents Consumption Value by Application (2024-2029) & (USD Million)
Table 147. Middle East & Africa Immunological Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 148. Middle East & Africa Immunological Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 149. Immunological Agents Raw Material
Table 150. Key Suppliers of Immunological Agents Raw Materials
Table 1. Global Immunological Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Immunological Agents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Immunological Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Immunological Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Abbott Company Information, Head Office, and Major Competitors
Table 6. Abbott Major Business
Table 7. Abbott Immunological Agents Product and Solutions
Table 8. Abbott Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Abbott Recent Developments and Future Plans
Table 10. Organon Company Information, Head Office, and Major Competitors
Table 11. Organon Major Business
Table 12. Organon Immunological Agents Product and Solutions
Table 13. Organon Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Organon Recent Developments and Future Plans
Table 15. Pfizer Company Information, Head Office, and Major Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Immunological Agents Product and Solutions
Table 18. Pfizer Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Pfizer Recent Developments and Future Plans
Table 20. Sandoz Company Information, Head Office, and Major Competitors
Table 21. Sandoz Major Business
Table 22. Sandoz Immunological Agents Product and Solutions
Table 23. Sandoz Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Sandoz Recent Developments and Future Plans
Table 25. Amneal Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 26. Amneal Pharmaceuticals Major Business
Table 27. Amneal Pharmaceuticals Immunological Agents Product and Solutions
Table 28. Amneal Pharmaceuticals Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Amneal Pharmaceuticals Recent Developments and Future Plans
Table 30. Apotex Company Information, Head Office, and Major Competitors
Table 31. Apotex Major Business
Table 32. Apotex Immunological Agents Product and Solutions
Table 33. Apotex Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Apotex Recent Developments and Future Plans
Table 35. Teva Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 36. Teva Pharmaceuticals Major Business
Table 37. Teva Pharmaceuticals Immunological Agents Product and Solutions
Table 38. Teva Pharmaceuticals Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Teva Pharmaceuticals Recent Developments and Future Plans
Table 40. Biocon Company Information, Head Office, and Major Competitors
Table 41. Biocon Major Business
Table 42. Biocon Immunological Agents Product and Solutions
Table 43. Biocon Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Biocon Recent Developments and Future Plans
Table 45. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
Table 46. Bristol Myers Squibb Major Business
Table 47. Bristol Myers Squibb Immunological Agents Product and Solutions
Table 48. Bristol Myers Squibb Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Bristol Myers Squibb Recent Developments and Future Plans
Table 50. Merck Company Information, Head Office, and Major Competitors
Table 51. Merck Major Business
Table 52. Merck Immunological Agents Product and Solutions
Table 53. Merck Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Merck Recent Developments and Future Plans
Table 55. CSL Behring Company Information, Head Office, and Major Competitors
Table 56. CSL Behring Major Business
Table 57. CSL Behring Immunological Agents Product and Solutions
Table 58. CSL Behring Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. CSL Behring Recent Developments and Future Plans
Table 60. Sanofi Company Information, Head Office, and Major Competitors
Table 61. Sanofi Major Business
Table 62. Sanofi Immunological Agents Product and Solutions
Table 63. Sanofi Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Sanofi Recent Developments and Future Plans
Table 65. Leading Pharma Company Information, Head Office, and Major Competitors
Table 66. Leading Pharma Major Business
Table 67. Leading Pharma Immunological Agents Product and Solutions
Table 68. Leading Pharma Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Leading Pharma Recent Developments and Future Plans
Table 70. Accord Healthcare Inc Company Information, Head Office, and Major Competitors
Table 71. Accord Healthcare Inc Major Business
Table 72. Accord Healthcare Inc Immunological Agents Product and Solutions
Table 73. Accord Healthcare Inc Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Accord Healthcare Inc Recent Developments and Future Plans
Table 75. Amgen Company Information, Head Office, and Major Competitors
Table 76. Amgen Major Business
Table 77. Amgen Immunological Agents Product and Solutions
Table 78. Amgen Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Amgen Recent Developments and Future Plans
Table 80. Nabi Biopharmaceuticals Company Information, Head Office, and Major Competitors
Table 81. Nabi Biopharmaceuticals Major Business
Table 82. Nabi Biopharmaceuticals Immunological Agents Product and Solutions
Table 83. Nabi Biopharmaceuticals Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Nabi Biopharmaceuticals Recent Developments and Future Plans
Table 85. Ascend Laboratories Company Information, Head Office, and Major Competitors
Table 86. Ascend Laboratories Major Business
Table 87. Ascend Laboratories Immunological Agents Product and Solutions
Table 88. Ascend Laboratories Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Ascend Laboratories Recent Developments and Future Plans
Table 90. Camber Pharmaceuticals Inc Company Information, Head Office, and Major Competitors
Table 91. Camber Pharmaceuticals Inc Major Business
Table 92. Camber Pharmaceuticals Inc Immunological Agents Product and Solutions
Table 93. Camber Pharmaceuticals Inc Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Camber Pharmaceuticals Inc Recent Developments and Future Plans
Table 95. Grifols USA Company Information, Head Office, and Major Competitors
Table 96. Grifols USA Major Business
Table 97. Grifols USA Immunological Agents Product and Solutions
Table 98. Grifols USA Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Grifols USA Recent Developments and Future Plans
Table 100. JOM Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 101. JOM Pharmaceuticals Major Business
Table 102. JOM Pharmaceuticals Immunological Agents Product and Solutions
Table 103. JOM Pharmaceuticals Immunological Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. JOM Pharmaceuticals Recent Developments and Future Plans
Table 105. Global Immunological Agents Revenue (USD Million) by Players (2018-2023)
Table 106. Global Immunological Agents Revenue Share by Players (2018-2023)
Table 107. Breakdown of Immunological Agents by Company Type (Tier 1, Tier 2, and Tier 3)
Table 108. Market Position of Players in Immunological Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 109. Head Office of Key Immunological Agents Players
Table 110. Immunological Agents Market: Company Product Type Footprint
Table 111. Immunological Agents Market: Company Product Application Footprint
Table 112. Immunological Agents New Market Entrants and Barriers to Market Entry
Table 113. Immunological Agents Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Immunological Agents Consumption Value (USD Million) by Type (2018-2023)
Table 115. Global Immunological Agents Consumption Value Share by Type (2018-2023)
Table 116. Global Immunological Agents Consumption Value Forecast by Type (2024-2029)
Table 117. Global Immunological Agents Consumption Value by Application (2018-2023)
Table 118. Global Immunological Agents Consumption Value Forecast by Application (2024-2029)
Table 119. North America Immunological Agents Consumption Value by Type (2018-2023) & (USD Million)
Table 120. North America Immunological Agents Consumption Value by Type (2024-2029) & (USD Million)
Table 121. North America Immunological Agents Consumption Value by Application (2018-2023) & (USD Million)
Table 122. North America Immunological Agents Consumption Value by Application (2024-2029) & (USD Million)
Table 123. North America Immunological Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 124. North America Immunological Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 125. Europe Immunological Agents Consumption Value by Type (2018-2023) & (USD Million)
Table 126. Europe Immunological Agents Consumption Value by Type (2024-2029) & (USD Million)
Table 127. Europe Immunological Agents Consumption Value by Application (2018-2023) & (USD Million)
Table 128. Europe Immunological Agents Consumption Value by Application (2024-2029) & (USD Million)
Table 129. Europe Immunological Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Immunological Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Immunological Agents Consumption Value by Type (2018-2023) & (USD Million)
Table 132. Asia-Pacific Immunological Agents Consumption Value by Type (2024-2029) & (USD Million)
Table 133. Asia-Pacific Immunological Agents Consumption Value by Application (2018-2023) & (USD Million)
Table 134. Asia-Pacific Immunological Agents Consumption Value by Application (2024-2029) & (USD Million)
Table 135. Asia-Pacific Immunological Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 136. Asia-Pacific Immunological Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 137. South America Immunological Agents Consumption Value by Type (2018-2023) & (USD Million)
Table 138. South America Immunological Agents Consumption Value by Type (2024-2029) & (USD Million)
Table 139. South America Immunological Agents Consumption Value by Application (2018-2023) & (USD Million)
Table 140. South America Immunological Agents Consumption Value by Application (2024-2029) & (USD Million)
Table 141. South America Immunological Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 142. South America Immunological Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 143. Middle East & Africa Immunological Agents Consumption Value by Type (2018-2023) & (USD Million)
Table 144. Middle East & Africa Immunological Agents Consumption Value by Type (2024-2029) & (USD Million)
Table 145. Middle East & Africa Immunological Agents Consumption Value by Application (2018-2023) & (USD Million)
Table 146. Middle East & Africa Immunological Agents Consumption Value by Application (2024-2029) & (USD Million)
Table 147. Middle East & Africa Immunological Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 148. Middle East & Africa Immunological Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 149. Immunological Agents Raw Material
Table 150. Key Suppliers of Immunological Agents Raw Materials
LIST OF FIGURES
Figure 1. Immunological Agents Picture
Figure 2. Global Immunological Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Immunological Agents Consumption Value Market Share by Type in 2022
Figure 4. Antirheumatic Drugs (DMARDs)
Figure 5. Immune Globulins
Figure 6. Immunomodulatory Agents
Figure 7. Immunosuppressive Agents
Figure 8. Monoclonal Antibodies
Figure 9. Other
Figure 10. Global Immunological Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 11. Immunological Agents Consumption Value Market Share by Application in 2022
Figure 12. Hospital Picture
Figure 13. Clinics Picture
Figure 14. Others Picture
Figure 15. Global Immunological Agents Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Immunological Agents Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Immunological Agents Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Immunological Agents Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Immunological Agents Consumption Value Market Share by Region in 2022
Figure 20. North America Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Immunological Agents Revenue Share by Players in 2022
Figure 26. Immunological Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Immunological Agents Market Share in 2022
Figure 28. Global Top 6 Players Immunological Agents Market Share in 2022
Figure 29. Global Immunological Agents Consumption Value Share by Type (2018-2023)
Figure 30. Global Immunological Agents Market Share Forecast by Type (2024-2029)
Figure 31. Global Immunological Agents Consumption Value Share by Application (2018-2023)
Figure 32. Global Immunological Agents Market Share Forecast by Application (2024-2029)
Figure 33. North America Immunological Agents Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Immunological Agents Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Immunological Agents Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Immunological Agents Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Immunological Agents Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Immunological Agents Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 43. France Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Immunological Agents Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Immunological Agents Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Immunological Agents Consumption Value Market Share by Region (2018-2029)
Figure 50. China Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 53. India Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Immunological Agents Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Immunological Agents Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Immunological Agents Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Immunological Agents Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Immunological Agents Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Immunological Agents Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 67. Immunological Agents Market Drivers
Figure 68. Immunological Agents Market Restraints
Figure 69. Immunological Agents Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Immunological Agents in 2022
Figure 72. Manufacturing Process Analysis of Immunological Agents
Figure 73. Immunological Agents Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Immunological Agents Picture
Figure 2. Global Immunological Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Immunological Agents Consumption Value Market Share by Type in 2022
Figure 4. Antirheumatic Drugs (DMARDs)
Figure 5. Immune Globulins
Figure 6. Immunomodulatory Agents
Figure 7. Immunosuppressive Agents
Figure 8. Monoclonal Antibodies
Figure 9. Other
Figure 10. Global Immunological Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 11. Immunological Agents Consumption Value Market Share by Application in 2022
Figure 12. Hospital Picture
Figure 13. Clinics Picture
Figure 14. Others Picture
Figure 15. Global Immunological Agents Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Immunological Agents Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Immunological Agents Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Immunological Agents Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Immunological Agents Consumption Value Market Share by Region in 2022
Figure 20. North America Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Immunological Agents Revenue Share by Players in 2022
Figure 26. Immunological Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Immunological Agents Market Share in 2022
Figure 28. Global Top 6 Players Immunological Agents Market Share in 2022
Figure 29. Global Immunological Agents Consumption Value Share by Type (2018-2023)
Figure 30. Global Immunological Agents Market Share Forecast by Type (2024-2029)
Figure 31. Global Immunological Agents Consumption Value Share by Application (2018-2023)
Figure 32. Global Immunological Agents Market Share Forecast by Application (2024-2029)
Figure 33. North America Immunological Agents Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Immunological Agents Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Immunological Agents Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Immunological Agents Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Immunological Agents Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Immunological Agents Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 43. France Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Immunological Agents Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Immunological Agents Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Immunological Agents Consumption Value Market Share by Region (2018-2029)
Figure 50. China Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 53. India Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Immunological Agents Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Immunological Agents Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Immunological Agents Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Immunological Agents Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Immunological Agents Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Immunological Agents Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Immunological Agents Consumption Value (2018-2029) & (USD Million)
Figure 67. Immunological Agents Market Drivers
Figure 68. Immunological Agents Market Restraints
Figure 69. Immunological Agents Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Immunological Agents in 2022
Figure 72. Manufacturing Process Analysis of Immunological Agents
Figure 73. Immunological Agents Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
